Clinical trial
Long-Term Sulfonylurea Response in ABCC8 Neonatal Diabetes (SuResponsSUR)
NCT02624830
Study timeline
Study start (actual)2019-02-15Date precision: day
Registry last updated2020-02-12
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Permanent Neonatal Diabetes Mellitusunresolved
Interventions
SulfonylureaDRUG
Sponsors & collaborators
Haukeland University Hospitallead sponsor
University of Bergencollaborator
University of Exetercollaborator
Royal Devon and Exeter NHS Foundation Trustcollaborator
Hôpital Necker-Enfants Maladescollaborator
University of Rome Tor Vergatacollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02624830 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.